Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain

AIDS

Volumn 19, Issue 13, 2005, Pages 1361-1365

  Arribas, J R ^a,b   Gonzalez Garcia J J ^a   Lorenzo, A ^a   Montero, D ^a   Ladron De Guevara C ^a   Montes, M ^a   Hernandez S ^a   Pacheco, R ^a   Pena J M ^a   Vazquez J J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PREVALENCE; PRIORITY JOURNAL; SPAIN; VIRUS HEPATITIS; VIRUS REPLICATION;

EID: 29144477379     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000180787.10553.b2     Document Type: Article

References (13)

1. Gonzalez-Garcia JJ, Mahillo B, Hernandez S, Pacheco R, Diz S, Garcia P, et al. Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study. Enferm Infecc Microbiol Clin 2005; 23:340-348.
2. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34:404-410.
3. Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, El Younsi M, et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 2000; 1:15-22.
4. Modahl LE, Lai MM. The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J Virol 2000; 74:7375-7380.
5. Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, Rockstroh J, et al. Care of patients with chronic hepatitis B and HIV coinfection: recommendations from an HIV-HBV International Panel. AIDS 2005; 19:221-240.
6. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 2000; 32:824-827.
7. Buti M, Esteban R, Jardi R, Allende H, Baselga JM, Guardia J. Epidemiology of delta infection in Spain. J Med Virol 1988; 26:327-332.
8. Navascues CA, Rodriguez M, Sotorrio NG, Sala P, Linares A, Suarez A, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995; 90:1981-1984.
9. Martin-Carbonero L, Barreiro P, Jimenez R, et al. Chronic hepatitis B may increase HCV clearance in HIV-HCV co-infected patients. 44th Interscience Conference of Antimicrobial Agents and Chemotherapy. Washington DC, October-November 2004 [abstract V-1153].
10. Eyster ME, Sanders JC, Battegay M, Di Bisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 1995; 40:1583-1588.
11. Pol S, Wesenfelder L, Dubois F, Roingeard P, Carnot F, Driss F, et al. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers. J Viral Hepat 1994; 1:131-137.
12. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14:64-67.
13. Taniguchi M, Shakil AO, Vargas HE, Laskus T, Demetris AJ, Gayowski T, et al. Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transpl 2000; 6:92-96.